Show Menu
Cheatography

MKOFTEN Timeline Cheat Sheet (DRAFT) by

Timeline of Project MKOFTEN

This is a draft cheat sheet. It is a work in progress and is not finished yet.

Background and Context

Early 1960s
MKULTRA seeks to expand research beyond LSD and tradit­ional psycho­active drugs.
 
Project focuses on behavi­or-­mod­ifying drugs, chemical agents, and “black magic” experi­men­tation, blending pharma­cology with esoteric practices.
 
Intended purpose: explore ways to manipulate human behavior, potent­ially for assass­ina­tion, espionage, or mind control.
Key Figures
Sidney Gottlieb: MKULTRA chemist overseeing many subpro­jects.
 
U.S. Army and Navy collab­ora­tors: Provided chemical and biological agents.
 
Occult advisors: Occasi­onally consulted to explore ritual­istic or psycho­logical effects.
 
MKOFTEN is part of MKULTRA Subpro­jects 8, 10, and 19, depending on specific sources, showing overla­pping objectives with broader mind-c­ontrol research.

1960–1962: Planning and Early Experi­ments

CIA identifies need for “practical applic­ations” of behavi­or-­mod­ifying chemicals in covert operat­ions.
MKOFTEN is conceived to:
Test unconv­ent­ional chemical agents on animals and eventually humans.
 
Invest­igate links between psycho­tropic substances and sugges­tib­ility.
 
Examine effects of drugs on aggres­sion, fear, and compli­ance.
Initial steps:
Animal trials using halluc­ino­gens, stimul­ants, and sedatives.
 
Recording physio­logical responses: heart rate, blood pressure, stress markers.
 
Parallel psycho­logical studies exploring ritual­istic or symbolic frameworks for control.

1962–1965: Human Testing Phase

Selection of Subjects
Volunteers (often military personnel, prisoners, or psychi­atric patients) used in covert drug trials.
 
Ethical oversight minimal or non-ex­istent.
 
Experi­ments sometimes overlapped with other MKULTRA programs like Montreal Experi­ments.
Drugs Tested
High-p­otency halluc­inogens (LSD deriva­tives, psiloc­ybin).
 
Hypnotics, sedatives, and dissoc­iative agents (e.g., scopol­amine, PCP).
 
Experi­mental compounds designed for aggression modulation or fear induction.
Experi­mental Methods
Testing both isolated chemical effects and combined pharma­col­ogi­cal­/ps­ych­olo­gical stimuli.
 
Behavioral endpoints included: Compliance with instru­ctions. Emotional breakdown under stress. Induced halluc­ina­tions and altered percep­tion.
Military & Occult Inters­ection
Some experi­ments involved ritual­istic enviro­nments or symbols, intended to amplify sugges­tib­ility.
 
Reports indicate testing of ceremonial contexts or symbolic triggers alongside drugs, though docume­ntation is sparse.
 

1965–1967: Expansion and Operat­ion­ali­sation

CIA begins exploring operat­ional applic­ations of MKOFTEN findings:
Field-­testing in covert operations to influence enemy or asset behavior.
 
Integr­ation with assass­ination research or interr­ogation techni­ques.
Experi­ments expand to:
Multiple agents in combin­ation (e.g., LSD plus stimul­ants).
 
Testing long-term effects of repeated exposure.
 
Animal­-to­-human transl­ational studies for aggression and fear condit­ioning.
Docume­ntation & Monitoring
Many records remain classified or destroyed, but surviving documents show: Emphasis on behavioral predic­tab­ility under chemical influence. Trials involving “psychic” or ritual­istic triggers to test psycho­logical manipu­lation

1967–1970: Decline and Termin­ation

By late 1960s, MKOFTEN is winding down due to:
Incons­istent results with mind control object­ives.
 
Ethical and legal concerns becoming more prominent.
 
Overlap with other MKULTRA subpro­jects reducing the need for separate MKOFTEN experi­ments.
Safe termin­ation procedures included:
Destru­ction of most experi­mental data.
 
Withdrawal of human test subjects from ongoing trials.
 
Reallo­cation of chemicals and methods to other MKULTRA programs.

1970s: Public Exposure

Invest­iga­tions by the Church Committee (1975) and Rockef­eller Commission begin uncovering the scope of MKULTRA subpro­jects, including MKOFTEN.
Findings highlight:
Use of experi­mental drugs on humans without consent.
 
Attempts to manipulate behavior using chemical and psycho­logical methods simult­ane­ously.
 
CIA interest in “exotic” or occult method­ologies for influe­ncing minds.
MKOFTEN is cited as an example of the CIA’s willin­gness to explore ethically and scient­ifi­cally dubious avenues in pursuit of operat­ional advantage.
 

Key Features of MKOFTEN

Focus on Behavior Modifi­cation
Targeted aggres­sion, fear response, and compli­ance.
 
Combin­ation of drugs and psycho­logical stimuli.
Experi­mental Subjects
Animals first, then humans (military, psychi­atric patients, prison­ers).
 
Non-co­nse­nting subjects in some trials.
Drug Use
Halluc­inogens (LSD, psiloc­ybin).
 
Dissoc­iatives (scopo­lamine, PCP).
 
Sedatives and experi­mental chemical agents.
Occult and Ritual Integr­ation
Some testing enviro­nments incorp­orated ritual­istic or symbolic elements.
 
Goal: explore psycho­logical amplif­ication of drug effects.
Ethical Violations
No informed consent for human trials.
 
Long-term psycho­logical harm largely unmoni­tored.
 
Blurred lines between scientific research and clande­stine operat­ions.

Long-Term Impact

MKOFTEN unders­cores MKULTRA’s reach into fringe, experi­mental, and ethically dubious methods.
Research influe­nced: Later CIA interest in chemical incapa­cit­ation and interr­ogation techni­ques. Broader unders­tanding (albeit unreli­able) of behavioral pharma­cology.
Demons­trates CIA willin­gness to combine science, psycho­logy, and esoteric experi­men­tation in pursuit of mind control object­ives.